The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Encompass Health Corp shares valued at $710,919 were sold by COLTHARP DOUGLAS E on Nov 13 ’23. At $63.39 per share, COLTHARP DOUGLAS E sold 11,215 shares. The insider’s holdings dropped to 116,293 shares worth approximately $9.42 million following the completion of this transaction.
Also, Charbonneau Elissa Joy sold 8,294 shares, netting a total of over 577,097 in proceeds. Following the sale of shares at $69.58 each, the insider now holds 23,081 shares.
Before that, Tarr Mark J had sold 25,330 shares from its account. In a trade valued at $1,799,950, the President & CEO traded Encompass Health Corp shares for $71.06 each. Upon closing the transaction, the insider’s holdings decreased to 25,330 shares, worth approximately $40.29 million.
As published in their initiating research note from Barclays on March 06, 2024, Encompass Health Corp [EHC] has been an Overweight and the price target has been revised to $95. Analysts at Barclays started covering the stock with ‘”an Equal weight”‘ outlook in a report released in mid March. As of September 24, 2021, UBS has initiated its “Buy” rating for EHC. Earlier on August 02, 2021, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for EHC stock which previously was a “an Outperform”.
Analyzing EHC Stock Performance
During the last five days, there has been a surge of approximately 4.23%. Over the course of the year, Encompass Health Corp shares have jumped approximately 21.40%. Shares of the company reached a 52-week high of $83.73 on 03/28/24 and a 52-week low of $65.99 on 01/02/24. A 50-day SMA is recorded $75.20, while a 200-day SMA reached $69.02. Nevertheless, trading volume fell to 0.59 million shares from 0.85 million shares the previous day.
Support And Resistance Levels for Encompass Health Corp (EHC)
According to the 24-hour chart, there is a support level at 80.34, which, if violated, would cause prices to drop to 79.67. In the upper region, resistance lies at 82.26. The next price resistance is at 83.51. RSI (Relative Strength Index) is 63.57 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.16, which suggests the price will increase in the coming days. Percent R is at 28.86%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Encompass Health Corp subject to short interest?
Stocks of Encompass Health Corp saw a sharp steep in short interest on Mar 15, 2024 dropping by -0.17 million shares to 2.29 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 2.46 million shares. A decline of -7.42% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.69 of the overall float, the days-to-cover ratio (short ratio) decline to 3.69.
